BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26502731)

  • 21. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
    Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
    J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
    Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
    Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
    Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
    J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Critical m
    Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X
    Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential value of expression of receptor accessory protein 4 for evaluating the prognosis of lower-grade glioma patients.
    Luo S; Liu Z; Chang H; Cheng X; Qian R; Gao Y; Hou C
    Aging (Albany NY); 2024 Mar; 16(7):6188-6211. PubMed ID: 38552216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profile as a prognostic factor in high-grade gliomas.
    Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
    Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
    Wang F; Luo Y; Li C; Chen L
    Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
    Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
    Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR125a-5p acting as a novel Gab2 suppressor inhibits invasion of glioma.
    Sun L; Zhang B; Liu Y; Shi L; Li H; Lu S
    Mol Carcinog; 2016 Jan; 55(1):40-51. PubMed ID: 25598421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
    Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
    J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.